Abstract
Two new antibiotics, sansanmycins B and C, were isolated from Streptomyces sp. SS. Their structures were elucidated by extensive 1D and 2D NMR and MS spectral analyses. Sansanmycins B and C exhibited inhibitory activity against our test strain of Pseudomonas aeruginosa with MIC values of 8.0 and 16 μg/ml, respectively. Sansanmycin B also exhibited inhibitory activity against Mycobacterium tuberculosis H37Rv and multidrug-resistant Mycobacterium tuberculosis, with the MIC values ranging from 8.0 to 20 μg/ml.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xie, Y., Xu, H., Si, S. et al. Sansanmycins B and C, New Components of Sansanmycins. J Antibiot 61, 237–240 (2008). https://doi.org/10.1038/ja.2008.34
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2008.34
Keywords
This article is cited by
-
Bioprospecting of unexplored halophilic actinobacteria against human infectious pathogens
3 Biotech (2023)
-
GKK1032C, a new alkaloid compound from the endophytic fungus Penicillium sp. CPCC 400817 with activity against methicillin-resistant S. aureus
The Journal of Antibiotics (2019)
-
Mechanism of action of nucleoside antibacterial natural product antibiotics
The Journal of Antibiotics (2019)
-
Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis
The Journal of Antibiotics (2019)
-
Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis
Nature Communications (2017)